Joey Azofeifa
CEO Arpeggio Biosciences
Dr. Azofeifa is the CEO and co-founder of Arpeggio Bio, a discovery stage biotech using high throughput transcriptomics to directly target cellular networks in cancer. Joey received his PhD in Computer Science from the University of Colorado where he focused his research at the intersection of machine learning and functional genomics. Joey also trained at Merck and FORMA therapeutics in preclinical and translational drug discovery before founding Arpeggio. He was recognized as a Forbes 30-under-30 in healthcare in 2020.